Literature DB >> 420653

Effect of kanamycin sulfate on the endocochlear dc potential of guinea pigs.

S Asakuma, L D Lowry, J B Snow.   

Abstract

The magnitudes of the endocochlear dc potential (EP) during adequate ventilation and during five minutes of anoxia were recorded in control guinea pigs and guinea pigs administered various dosages of kanamycin sulfate. The magnitudes of the EP after five minutes of anoxia were -44.6 +/- 5.9 mV in the controls and +26.6 +/- 9.9 mV in the guinea pigs that received kanamycin for seven or ten days. This change occurred after five or six days of administration of kanamycin. However, there was no significant change in the magnitude ot the EP with adequate ventilation with kanamycin intoxication. There is a significant correlation between the magnitude of the negative EP and the maximum output of the cochlear microphonics (r = -.770, P less than .001). These results suggest that the EP may not be the mathematical summation of the positive electrogenic potential and the negative diffusion potential. The mechanism for generating the negative EP during anoxia may have some relationship to hair cell integrity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 420653     DOI: 10.1001/archotol.1979.00790150035009

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  3 in total

1.  Profiles of resting potentials across the stria vascularis in kanamycin-deafened guinea pigs.

Authors:  S Komune; H Inoue; S Wakizono; T Nakagawa; T Kimitsuki; T Uemura
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

2.  Origin of the endolymphatic DC potential in the cochlea and ampulla of the guinea pig.

Authors:  T Ono; M Tachibana
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

3.  Progressive irreversible hearing loss is caused by stria vascularis degeneration in an Slc26a4-insufficient mouse model of large vestibular aqueduct syndrome.

Authors:  T Ito; A Nishio; P Wangemann; A J Griffith
Journal:  Neuroscience       Date:  2015-09-09       Impact factor: 3.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.